How To Control The Tuberculosis And HIV/AIDS Dual Epidemic

Philip Anochie

ISBN 10: 3659694053 / ISBN 13: 9783659694059

Editore: LAP LAMBERT Academic Publishing Jun 2018, 2018

Riguardo questo articolo

Neuware -TB patients can be offered an HIV test; indeed , research shows that TB patients are more likely to accept HIV testing than the general population. This means that TB programmes can make a major contribution to identifying eligible candidates for ARV treatment. Many people , including those living with HIV, do not know that TB is curable. This is a basic message and one thing that is failing to get through. We should know how to get the message to policy- makers and funders that more drugs are needed for both diseases. It is not ¿either/or¿, there is no point providing ARVs only for patients to die of TB for lack of TB resources. Similarly , TB efforts alone are insufficient. HIV/AIDS is dramatically fuelling the TB epidemic in sub-Saharan Africa, where up to 70% of TB patients are co-infected with HIV in some countries. For many years efforts to tackle TB and HIV have been largely separate, despite the overlapping epidemiology. Improved collaboration between TB and HIV/AIDS programmes will lead to more effective control of TB among HIV- infected people and to significant public health gains.

Codice articolo 9783659694059

Dati bibliografici

• Titolo: How To Control The Tuberculosis And HIV/AIDS Dual Epidemic
• Editore: LAP LAMBERT Academic Publishing Jun 2018
• Data di pubblicazione: 2018
• Lingua: Inglese
• ISBN 10: 3659694053
• ISBN 13: 9783659694059
• Rilegatura: Taschenbuch
• Condizione: Neu
• Dimensioni: 220 L x 150 A x 4 P (millimetri) 220 millimetri di larghezza per 150 millimetri di altezza per 4 millimetri di profondità
• Peso: 96 grammi

Descrizione articolo

Riassunto

TB patients can be offered an HIV test; indeed , research shows that TB patients are more likely to accept HIV testing than the general population. This means that TB programmes can make a major contribution to identifying eligible candidates for ARV treatment. Many people , including those living with HIV, do not know that TB is curable. This is a basic message and one thing that is failing to get through. We should know how to get the message to policy- makers and funders that more drugs are needed for both diseases. It is not “either/or’, there is no point providing ARVs only for patients to die of TB for lack of TB resources. Similarly , TB efforts alone are insufficient. HIV/AIDS is dramatically fuelling the TB epidemic in sub-Saharan Africa, where up to 70% of TB patients are co-infected with HIV in some countries. For many years efforts to tackle TB and HIV have been largely separate, despite the overlapping epidemiology. Improved collaboration between TB and HIV/AIDS programmes will lead to more effective control of TB among HIV- infected people and to significant public health gains.